Latest news on Laboratorytalk categorised by supplier
AbD Serotec
Address:
Division of MorphoSys
Lena-Christ-Str. 48
82152 Martinsried/Planegg
Germany
Telephone: (Germany) +49 89 899 27 234
http://www.a-by-d.com
Our RSS feed for news from AbD Serotec
Request to receive our free email newsletter each week
Listing of all 17 news releases from AbD Serotec:
Easy antibody labelling with Lynx conjugation kits
The Lynx labels are covalently and directionally conjugated to the user's antibody in a controlled process at near neutral pH, requiring no subsequent desalting steps
News from AbD Serotec ( 5 February 2008)
Interactive human CD marker references are online
Valuable educational resource from AbD Serotec helps scientists determine specific markers for analysing human cell types at different stages of differentiation from a pluripotent stem cell
News from AbD Serotec ( 5 February 2008)
HuCAL-Fab fragment neutralises HIV-1 strains
Technical background article NIDDK scientists detect new epitope on HIV-1 protein gp41 using AbD Serotec-generated recombinant mini-antibody; research published in the Journal of Virology and abstract available on PubMed
News from AbD Serotec (10 January 2008)
Reference poster for neuroscientists
Neurotransmitter pathways poster is first to feature four major neurotransmitter systems with normal and abnormal pathways shown side by side, and describe therapeutics for related clinical disorders
News from AbD Serotec (25 October 2007)
Triple colour reagent for studying canine T cells
To assist researchers AbD Serotec offers singular antibodies to canine T and B cell markers, plus a range of dual colour reagents for detecting CD3/CD4, CD4/CD8 and CD3/CD8
News from AbD Serotec (24 July 2007)
Free copy of HuCAL antibodies technical manual
HuCAL technology is revolutionising the way monoclonal antibodies are generated and offers advantages over traditional animal-based methods - including speed, specificity and production technology
News from AbD Serotec (20 July 2007)
Antibody and His-tagged protein purification
AbD Serotec's Proteus purification kits combine the separation quality of gravity flow columns with the speed and ease-of-use of spin columns
News from AbD Serotec (19 July 2007)
Source book is the essential antibody reference
Combining all the antibodies from Serotec, Biogenesis and Oxford Biotechnology, it also includes a wide range of antigens, kits, and accessoriss - all supported by the AbD Serotec quality guarantee
News from AbD Serotec ( 4 July 2007)
AbD Serotec to sell fluorescent reagents
Agreement covers the use Thermo Scientific DyLight Dyes in combination with AbD Serotec's research antibodies to prepare a series of fluorescent reagents
News from AbD Serotec (13 February 2007)
Disease pathways found with HuCAL-based antibodies
User application article Scientists at Hokkaido University to analyse Parkinson's and Alzheimer's disease pathways using HuCAL-based antibodies generated from the MorphoSys HuCAL gold antibody library
News from AbD Serotec ( 6 December 2006)
Antibody series established with Kazusa Institute
Antibodies by Design, a division of MorphoSys, Munich, has announced results of a research and development programme with renowned Japanese Kazusa DNA Research Institute, Kisarazu
News from AbD Serotec (19 May 2006)
Co-marketing of monoclonal antibodies
Antibodies by Design, a division of MorphoSys, and Chimera Biotec have announced the start of a co-marketing agreement between the two companies
News from AbD Serotec (22 February 2006)
HuCAL-based mini-antibodies in HIV research
User application article National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) scientists analyse HuCAL-based mini-antibodies as a potential basis for future HIV-1 therapeutics
News from AbD Serotec (25 November 2005)
Automation software increases antibody throughput
Relational database system improves the efficiency of internal data administration relating to customers, processes, storage, and shipment of materials
News from AbD Serotec ( 8 June 2005)
Agreement covers antibodies and peptides
Co-marketing agreement covering the rapid generation of monoclonal antibodies and complementary peptide-based services and products
News from AbD Serotec (19 April 2005)
Seeking therapies for bone cancer metastasis
User application article Bone metastases develop from virulent tumour cells that are spread through the body mostly via the circulation of the blood and which then settle in the medulla
News from AbD Serotec (23 March 2005)
Announcing the first recombinant antibody
Said to be the first in vitro derived recombinant antibody, it is targeted against Cyclophilin A, which is indicated to play an important role in the mechanism of protein folding
News from AbD Serotec ( 2 December 2004)
